
Bloomberg Intelligence
3mo ago·25m
Ackman Pitches $65 Billion UMG Deal to Move Listing to US
Watch Scarlet and Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.
Bloomberg Intelligence hosted by Paul Sweeney, Emily Graffeo, and Alexis Christoforous
-Matthew Bloxham, Bloomberg Intelligence Senior and Tech Analyst, discusses Bill Ackman's investment firm Pershing Square Capital Management pitching a deal to combine Universal Music Group with an acquisition vehicle publicly traded in the US.
-Mandeep Singh, Global Tech Research Head at Bloomberg Intelligence, discusses the latest on Broadcom. Anthropic confirmed plans to work with Broadcom and Google to power its operations.
-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in the biotech sector. Gilead Sciences agreed to buy private German biotech Tubulis GmbH in a deal worth up to $5 billion to boost its portfolio in cancer drug development. Novo Nordisk will price its new high-dose Wegovy shot at $399 a month for cash-pay patients, undercutting the cost of most doses of rival Eli Lilly & Co.’s Zepbound.
-Lloyd Arnold, BNEF Data Center Reporter, discusses data centers. The digital infrastructure boom is continuing apace despite jitters in equity markets and fears of a “bubble”. The capital expenditure of the 14 largest publicly owned data center operators globally is seen close to $750 billion this year against a little less than $450 billion last year.
See omnystudio.com/listener for privacy information.
Bloomberg Intelligence hosted by Paul Sweeney, Emily Graffeo, and Alexis Christoforous
-Matthew Bloxham, Bloomberg Intelligence Senior and Tech Analyst, discusses Bill Ackman's investment firm Pershing Square Capital Management pitching a deal to combine Universal Music Group with an acquisition vehicle publicly traded in the US.
-Mandeep Singh, Global Tech Research Head at Bloomberg Intelligence, discusses the latest on Broadcom. Anthropic confirmed plans to work with Broadcom and Google to power its operations.
-Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the latest in the biotech sector. Gilead Sciences agreed to buy private German biotech Tubulis GmbH in a deal worth up to $5 billion to boost its portfolio in cancer drug development. Novo Nordisk will price its new high-dose Wegovy shot at $399 a month for cash-pay patients, undercutting the cost of most doses of rival Eli Lilly & Co.’s Zepbound.
-Lloyd Arnold, BNEF Data Center Reporter, discusses data centers. The digital infrastructure boom is continuing apace despite jitters in equity markets and fears of a “bubble”. The capital expenditure of the 14 largest publicly owned data center operators globally is seen close to $750 billion this year against a little less than $450 billion last year.
See omnystudio.com/listener for privacy information.
Start Free Trial14 days free
Transcript
The full transcript is available with a free trial.
This is one of 120M+ episodes across 700K+ channels — fully transcribed, searchable, and queryable with AI on Matterfact.
14 days freeCancel anytime
Full transcriptsAI Q&ADeep search
Why Matterfact
Built for investment professionals
Executives are more candid on podcasts than earnings calls. Matterfact makes those conversations searchable, readable, and queryable with AI.
120M+episodes transcribed
Jensen Huang: "The demand for accelerated computing is incredible..."
Host: "How do you see AI changing the semiconductor landscape?"
Jensen: "Every data center is going to be accelerated..."
Start your free trial
Every day you wait, your competitors are finding
edge in conversations you're not hearing.
Full access to 120M+ transcribed episodes, AI-powered search, and unlimited Q&A — free for 14 days.
14 days free · Cancel anytime